Login to Your Account

Intercell Gets $9.5M Up Front In Potential $85M Merck Deal

By Cormac Sheridan

Wednesday, November 8, 2006
Intercell AG earned an up-front payment of $9.5 million and could receive up to $76 million more in milestones from an agreement with Merck Sharpe & Dhome Research Ltd., an arm of Merck & Co. Inc. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription